Cargando…
Are trial participants adequately safeguarded by the ethics committees—the Indian scenario?
Autores principales: | Thakkar, Karan, Billa, Gauri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058816/ https://www.ncbi.nlm.nih.gov/pubmed/24982635 http://dx.doi.org/10.3389/fphar.2014.00143 |
Ejemplares similares
-
Light at the end of the tunnel?: The Great Indian Pharmacoeconomics story
por: Thakkar, Karan B., et al.
Publicado: (2013) -
The concept of: Generic drugs and patented drugs vs. brand name drugs and non-proprietary (generic) name drugs
por: Thakkar, Karan B., et al.
Publicado: (2013) -
Safeguard Ethics
Publicado: (1916) -
Overview of the National Ethics Committee Registry for Biomedical and Health Research in India: Stepping up to safeguard the ethical aspect of research involving human participants
por: Venugopal, Balu, et al.
Publicado: (2023) -
A study to assess completeness of project application forms submitted to Institutional Ethics Committees (IEC) of a tertiary care hospital
por: Shetty, Yashashri C., et al.
Publicado: (2012)